Jonathan Stuart Kaplan

Array ( [id] => 7097668 [patent_doc_number] => 20050130127 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-16 [patent_title] => 'Coronavirus-like particles comprising functionally deleted genomes' [patent_app_type] => utility [patent_app_number] => 10/714534 [patent_app_country] => US [patent_app_date] => 2003-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 56 [patent_figures_cnt] => 56 [patent_no_of_words] => 29118 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20050130127.pdf [firstpage_image] =>[orig_patent_app_number] => 10714534 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7334463 [patent_doc_number] => 20040132011 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Method for detecting viral inactivating agents' [patent_app_type] => new [patent_app_number] => 10/685801 [patent_app_country] => US [patent_app_date] => 2003-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12994 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20040132011.pdf [firstpage_image] =>[orig_patent_app_number] => 10685801 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 797882 [patent_doc_number] => 07427468 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-09-23 [patent_title] => 'Anti-TSG101 antibodies and their uses for treatment of viral infections' [patent_app_type] => utility [patent_app_number] => 10/675979 [patent_app_country] => US [patent_app_date] => 2003-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 22511 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/427/07427468.pdf [firstpage_image] =>[orig_patent_app_number] => 10675979 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5842269 [patent_doc_number] => 20060121049 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Chimeric recombinant protein and in vitro diagnosis' [patent_app_type] => utility [patent_app_number] => 10/526765 [patent_app_country] => US [patent_app_date] => 2003-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7856 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20060121049.pdf [firstpage_image] =>[orig_patent_app_number] => 10526765 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7432295 [patent_doc_number] => 20040162253 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-19 [patent_title] => 'Antiviral oligonucleotides targeting HBV' [patent_app_type] => new [patent_app_number] => 10/661088 [patent_app_country] => US [patent_app_date] => 2003-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 35260 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20040162253.pdf [firstpage_image] =>[orig_patent_app_number] => 10661088 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7285897 [patent_doc_number] => 20040146522 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-29 [patent_title] => 'Multimerization of HIV-1 Vif protein as a therapeutic target' [patent_app_type] => new [patent_app_number] => 10/656441 [patent_app_country] => US [patent_app_date] => 2003-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14134 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20040146522.pdf [firstpage_image] =>[orig_patent_app_number] => 10656441 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 111865 [patent_doc_number] => 07713532 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-11 [patent_title] => 'HBV precore protein capable of forming particles' [patent_app_type] => utility [patent_app_number] => 10/526744 [patent_app_country] => US [patent_app_date] => 2003-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9217 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/713/07713532.pdf [firstpage_image] =>[orig_patent_app_number] => 10526744 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7473903 [patent_doc_number] => 20040121975 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-24 [patent_title] => 'Hepatitis C virus assays' [patent_app_type] => new [patent_app_number] => 10/639150 [patent_app_country] => US [patent_app_date] => 2003-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 6521 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20040121975.pdf [firstpage_image] =>[orig_patent_app_number] => 10639150 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 616301 [patent_doc_number] => 07144712 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-12-05 [patent_title] => 'Human hepatitis B virus core proteins as vaccine platforms and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 10/630074 [patent_app_country] => US [patent_app_date] => 2003-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 41999 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 163 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/144/07144712.pdf [firstpage_image] =>[orig_patent_app_number] => 10630074 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7164846 [patent_doc_number] => 20040076636 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-22 [patent_title] => 'HIV immunogenic complexes' [patent_app_type] => new [patent_app_number] => 10/612192 [patent_app_country] => US [patent_app_date] => 2003-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9285 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20040076636.pdf [firstpage_image] =>[orig_patent_app_number] => 10612192 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5655307 [patent_doc_number] => 20060141042 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Hollow nanoparticle having modified cysteine residue and drug with the use thereof' [patent_app_type] => utility [patent_app_number] => 10/519559 [patent_app_country] => US [patent_app_date] => 2003-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 9343 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0141/20060141042.pdf [firstpage_image] =>[orig_patent_app_number] => 10519559 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7219457 [patent_doc_number] => 20040072150 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Identification of oligonucleotides for the capture, detection and quantitation of hepatitis A viral nucleic acid' [patent_app_type] => new [patent_app_number] => 10/461126 [patent_app_country] => US [patent_app_date] => 2003-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13598 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20040072150.pdf [firstpage_image] =>[orig_patent_app_number] => 10461126 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5807236 [patent_doc_number] => 20060093590 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-04 [patent_title] => 'Pseudotyped retroviruses' [patent_app_type] => utility [patent_app_number] => 10/516578 [patent_app_country] => US [patent_app_date] => 2003-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 7647 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20060093590.pdf [firstpage_image] =>[orig_patent_app_number] => 10516578 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 378253 [patent_doc_number] => 07313357 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-12-25 [patent_title] => 'Method for typing and detecting HBV' [patent_app_type] => utility [patent_app_number] => 10/453792 [patent_app_country] => US [patent_app_date] => 2003-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 14580 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/313/07313357.pdf [firstpage_image] =>[orig_patent_app_number] => 10453792 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7465465 [patent_doc_number] => 20040101829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-27 [patent_title] => 'Protein that interacts with lipids and methods for treating hyperlipidemia' [patent_app_type] => new [patent_app_number] => 10/445724 [patent_app_country] => US [patent_app_date] => 2003-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 28274 [patent_no_of_claims] => 84 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20040101829.pdf [firstpage_image] =>[orig_patent_app_number] => 10445724 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7422765 [patent_doc_number] => 20040229335 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => 'Methods and compositions for the production of adenoviral vectors' [patent_app_type] => new [patent_app_number] => 10/439278 [patent_app_country] => US [patent_app_date] => 2003-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 26323 [patent_no_of_claims] => 80 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20040229335.pdf [firstpage_image] =>[orig_patent_app_number] => 10439278 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7463010 [patent_doc_number] => 20040053219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-18 [patent_title] => 'Method for analysing human immunodeficiency virus (HIV) phenotypic characteristics' [patent_app_type] => new [patent_app_number] => 10/436458 [patent_app_country] => US [patent_app_date] => 2003-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10942 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20040053219.pdf [firstpage_image] =>[orig_patent_app_number] => 10436458 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7465454 [patent_doc_number] => 20040101828 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-27 [patent_title] => 'Method for analysis of the phenoptypic characteristics of the human immunodeficiency virus (HIV)' [patent_app_type] => new [patent_app_number] => 10/435659 [patent_app_country] => US [patent_app_date] => 2003-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13695 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 243 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20040101828.pdf [firstpage_image] =>[orig_patent_app_number] => 10435659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7465454 [patent_doc_number] => 20040101828 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-27 [patent_title] => 'Method for analysis of the phenoptypic characteristics of the human immunodeficiency virus (HIV)' [patent_app_type] => new [patent_app_number] => 10/435659 [patent_app_country] => US [patent_app_date] => 2003-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13695 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 243 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20040101828.pdf [firstpage_image] =>[orig_patent_app_number] => 10435659 [rel_patent_id] =>[rel_patent_doc_number] =>)